Figures
- FIGURE 1
Bronchoscopic view a, c, e) before and b, d, f) after bronchoscopic resection of inflammatory myofibroblastic tumours.
- FIGURE 2
A representative overview and detail of inflammatory myofibroblastic tumour is shown. Haematoxylin and eosin stain a) 10× and b) 40×. c) Immunohistochemistry is positive in tumour cells for ALK (5A4 antibody, 20x), including the control appendix tissue showing negative myocytes and weakly positive ganglion cells (frame within panel (c)). d) Fluorescence in situ hybridisation analysis with an ALK rearrangement, note the split signals.
Vol 7 Issue 1
Table of Contents
Inflammatory myofibroblastic tumour of the central airways: treatment and molecular analysis
